Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to provide a surveillance system to monitor changes in the rate of mother to child HIV transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs.


Clinical Trial Description

The goal of the CO11 national cohort is to provide with CO1 a wider surveillance system to monitor changes in the rate of mother to child transmission and preventive practices in France and especially to identify the occurrence of toxicity in children exposed perinatally to antiretroviral drugs. The CO11 EPF enrolle HIV infected women who delivery in maternity generally smaller than CO1 maternity (15 sites in Paris area, 35 in mainland France and 4 in the DOM). Maternal clinical, biological and therapeutic data before and during pregnancy were collected at delivery, with simplified questionnaires. The children are examined clinically and biologically at birth, 6, 12 and 24 months. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03306251
Study type Observational
Source ANRS, Emerging Infectious Diseases
Contact Josiane WARSZAWSKI
Email josiane.warszawski@inserm.fr
Status Recruiting
Phase
Start date June 2005
Completion date March 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03235310 - Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention